GLP-1 coverage in California
Documented Medicaid fee-for-service status and insurance-mandate activity — not a decision for your member ID.
Sources last checked October 23, 2026
Spot an error? Report a correction
Medicaid (obesity / weight-loss)
KFF, "Medicaid Coverage of and Spending on GLP-1s", January 2026
This is the KFF January 2026 fee-for-service survey row for California. Managed-care plans in the same state can differ. GLP-1s prescribed for type 2 diabetes are covered by every state Medicaid program regardless of this row.
Medi-Cal no longer covers GLP-1 drugs for weight loss alone, effective January 1, 2026.
Wegovy, Zepbound, Saxenda, Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon and Trulicity are no longer covered when used only for weight loss. Prior authorizations for weight-loss use ended December 31, 2025.
Source: Medi-Cal Rx member notice: GLP-1 changes, 2026-01-01
Wegovy, Zepbound and Saxenda were removed from the Medi-Cal Rx Contract Drugs List. Claims for weight loss deny with Reject Code 70.
Source: Medi-Cal Rx provider notice, January 2026, 2026-01-01
Members under 21 may still qualify for weight-loss coverage if their prescriber or pharmacy submits a prior authorization request and it is approved, under the federal EPSDT benefit.
Source: Medi-Cal Rx budget policy updates FAQ, 2026-01-01
Members already taking a GLP-1 on or before January 1, 2026 who request a State Hearing within 10 days of a notice denying continued coverage may keep getting the drug while the hearing is pending.
Source: Medi-Cal Rx member notice: GLP-1 changes, 2026-01-01
The change implements the enacted 2025-26 State Budget. Medi-Cal Rx Customer Service Center: 1-800-977-2273, 24 hours a day, 7 days a week.
Source: Medi-Cal Rx budget policy updates FAQ, 2026-01-01
Diabetes
Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon and Trulicity remain covered for type 2 diabetes when the prescriber submits a diagnosis code. Wegovy is still covered for noncirrhotic MASH with a diagnosis code, and Wegovy for cardiovascular disease and Zepbound for obstructive sleep apnea can be requested through prior authorization.
Source: Medi-Cal Rx member notice: GLP-1 changes, 2026-01-01
State insurance-mandate activity
Pharmacy Times, "States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments", October 27, 2025
AB 575 — as of its last recorded legislative action, only "amended in Assembly," not signed into law, despite some outlets describing it as enacted. Check CA Legislative Information (https://leginfo.legislature.ca.gov) directly.
Also: HealthInsurance.org state coverage tracker (general), 2026. A headline about a bill is not the same as coverage on your card.
What to do with this
Medicaid survey rows and mandate bills are not a prior-authorization approval. Call the number on your ID card and ask whether the drug is covered for your diagnosis.
Full 5-step checklist →Related: All state pages · Medicaid by state · State laws · Cash-pay options